1. Sarkany RPE, Whitcombe DM, Cox TM. Molecular characterization of a ferrochelatase gene defect causing anomalous RNA splicing in Erythropoietic Protoporphyria. J. Invest. Dermatol. 102: 481-4 (1994)
  2. Sarkany RPE, Alexander GJMA, Cox TM. Recessive inheritance of Erythropoietic Protoporphyria with liver failure. The Lancet 343: 1394-1396 (1994)
  3. Sarkany RPE and Cox TM. Autosomal recessive erythropoietic protoporphyria: a syndrome of severe photosensitivity and hepatic failure. Quart. J. Med. 88: 541-49 (1995)
  4. Morris S, Elder G, Hawk J, Sarkany RPE. Ferrochelatase gene polymorphism analysis for accurate genetic counselling in erythropoietic protoporphyria. Br J Dermatol. 147:572-4 (2002)
  5. Sarkany RPE, Ross G, Willis F. Acquired Erythropoietic protoporphyria as a result of myelodysplasia causing loss of chromosome 18. Br J Dermatol. 155:464-6 (2006).
  6. Robert P E Sarkany, et al. Erythropoietic Uroporphyria Associated with Myeloid Malignancy Is Likely Distinct from Autosomal Recessive Congenital Erythropoietic Porphyria. Journal of Investigative Dermatology 131, 1172-1175 (2011)
  7. Tewari A, Sarkany RP, Young AR. UVA1 induces cyclobutane pyrimidine dimers but not 6-4 photoproducts in human skin in vivo. J Invest Dermatol. 2012 132:394-400.
  8. Tewari A, Lahmann C, Sarkany R, Bergemann J, Young AR.Human erythema and matrix metalloproteinase-1 mRNA induction, in vivo, share an action spectrum which suggests common chromophores. Photochem Photobiol Sci. 2012;11:216-23.
  9. Byrne M, Stefanato CM, Sarkany R. A photosensitive pseudolymphomatous eruption. Actinic reticuloid (AR). Clin Exp Dermatol. 2012;37:203-4.
  10. Tewari A, Grage MM, Harrison GI, Sarkany R, Young AR. UVA1 is skin deep: molecular and clinical implications. Photochem Photobiol Sci. 2013;12:95-103.
  11. Kerr AC, Ferguson J, Attili SK, Beattie PE, Coleman AJ, Dawe RS, Eberlein B, Goulden V, Ibbotson SH, Menage Hdu P, Moseley H, Novakovic L, Walker SL, Woods JA, Young AR, Sarkany RP . Ultraviolet A1 phototherapy: a British Photodermatology Group workshop report.. Clin Exp Dermatol. 2012 37:219-26.
  12. Sarkany RP. Photopatch testing comes of age. Br J Dermatol. 2012 166:912-3. (Commentary)
  13. Stein PE, Badminton MN, Barth JH, Rees DC, Sarkany R, Stewart MF, Cox TM Acute intermittent porphyria: fatal complications of treatment (lesson of the month 1) Clinical Medicine, 12: 293-4 (2012)
  14. Tewari A, Marsden J, Naik H, Benton EC, Sarkany R. Oral cholestyramine is not an effective treatment for uncomplicated erythropoietic protoporphyria. J Am Acad Dermatol. 2012;67:1383-4.
  15. Penny H, Frame S, Dickinson F, Garrett G, Young AR, Sarkany R, Chitalia N, Hampson G, Goldsmith D. Determinants of vitamin D status in long-term renal transplant patients. Clin Transplant. 2012 26:E617-23.
  16. Tewari A, Grage MM, Harrison GI, Sarkany R, Young AR. UVA1 is skin deep: molecular and clinical implications. Photochem Photobiol Sci. 2012;12:95-103.
  17. Kashiyama K, Nakazawa Y, Pilz DT, Guo C, Shimada M, Sasaki K, Fawcett H, Wing JF, Lewin SO, Carr L, Li TS, Yoshiura K, Utani A, Hirano A, Yamashita S, Greenblatt D, Nardo T, Stefanini M, McGibbon D, Sarkany R, Fassihi H, Takahashi Y, Nagayama Y, Mitsutake N, Lehmann AR, Ogi T. Malfunction of Nuclease ERCC1-XPF Results in Diverse Clinical Manifestations and Causes Cockayne Syndrome, Xeroderma Pigmentosum, and Fanconi Anemia. Am J Hum Genet. 2013;92:807-19.
  18. Gonçalo M, Ferguson J, Bonevalle A, Bruynzeel DP, Giménez-Arnau A, Goossens A, Kerr A, Lecha M, Neumann N, Niklasson B, Pigatto P, Rhodes LE, Rustemeyer T, Sarkany R, Thomas P, Wilkinson M. Photopatch testing: recommendations for a European photopatch test baseline series. Contact Dermatitis. 2013;68:239-43.
  19. Sarkany R. Congenital erythropoietic porphyria: bringing evidence-based practice to a rare disease. Br J Dermatol. 2012;167:709.
  20. Sarkany RPE. ‘The cutaneous porphyrias’. In: Burns T, et al. eds. Rook's Textbook of Dermatology 88h Edn. Oxford: Blackwell. 2010 (Chapter)
  21. Sarkany RPE (2011) ultraviolet radiation and the skin. In: Nriagu JO (ed.) Encyclopedia of Environmental Health, volume 5, pp. 469–482 Burlington: Elsevier. (Chapter)
  22. Agius E and Sarkany R. Thalidomide in 2nd Edition Handbook of Systemic Drug Treatment in Dermatology, Manson Publishing, 2012 (Chapter)
  23. Sarkany RPE. The molecular genetics of erythropoietic protoporphyria. Current Opinion in Dermatology 219-224 (1995).
  24. Cox TM, Alexander GJM and Sarkany RPE. Protoporphyria. Seminars in Liver Disease; 18: 85-93 (1998)
  25. Sarkany R.P.E. Porphyria: from Sir Walter Raleigh to molecular biology. Rheumaderm: current issues in rheumatology and dermatology. Ed. Mallia C and Uitto J. Advances in Experimental Medicine and Biology 455: 235-241 (1999)
  26. Sarkany R.P.E. The management of porphyria cutanea tarda. Clin Exp Dermatol 26:225-232 (2001)
  27. Sarkany R.P.E. Erythropoietic Protoporphyria (EPP) at 40: where are we now? Photodermatol Photoimmunol Photomed 18:147-52 (2002)
  28. Sarkany RPE. The porphyrias: a practical guide. Dermatology in Practice 9:6-9 (2001)
  29. Peters T and Sarkany RPE. Porphyria for the General Physician. Clin Med 5:275-281 (2005)
  30. Sarkany RP.Making sense of the porphyrias. Photodermatol Photoimmunol Photomed.24:102-8. (2008).
  31. Tewari A, Marsden J, Naik H, Benton EC, Sarkany RP. Oral cholestyramine is not an effective treatment for uncomplicated Erythropoietic Protoporphyria. Journal of the American Academy of Dermatology 67:1383-1384 (2012)
  32. Sarkany RPE, Alexander GJM, Cox TM. Recessive inheritance of erythropoietic protoporphyria with liver failure. The Lancet 344: 958-9 (1994)
  33. Sarkany RPE and Norris PG. Hepatic complications of erythropoietic protoporphyria. Brit. J. Dermatol. 130: 258 (1994)
  34. Sarkany RPE and Cox TM. Liver failure in erythropoietic protoporphyria. J. Am. Acad. Dermatol. 34: 540-1 (1996)
  35. Sarkany R. Clinical implications of advances in understanding the inheritance of erythropoietic protoporphyria. Br J Dermatol. 2010;162:1156-7. (Commentary)

Call 111 when you need medical help fast but it’s not a 999 emergencyNHS ChoicesThis site is brought to you by My Surgery Website